Bridging the gap between bioscience and engineering
Posted on 23/12/2017
UCL’s Department of Biochemical Engineering runs a series of UCL-accredited short courses in bioprocessing, designed specifically for industrialists, that can be taken as stand-alone modules or can be combined for Certificate, Diploma or Masters qualifications.
Courses are of 3-4 days duration and can be undertaken as stand-alone modules or can be combined for Certificate, Diploma or Masters qualifications. The programme has been developed in partnership with a team of industrialists and there is an emphasis on teaching through interactive problem solving case studies in small classes for effective learning.
By attending a Modular Training for the Bioprocess Industries (MBI®) course you can benefit from:
- Up-to-date skills and knowledge to rapidly develop validatable, efficient and robust processes
- A thorough knowledge of process options and engineering constraints
- A capacity to improve processes
- Updates staff in the latest technical and regulatory developments
- Increased flexibility, motivation, creativity and professional status for delegates
- Increased contact network
Upcoming modules include:
- Current Challenges in Mammalian Cell Processing – 22-24 January 2018
- Quality by Design for Effective Bioprocess Characterisation and Validation – 26 February – 1 March 2018
- Design of Experiments for Bioprocess Optimisation – 12-14 March 2018
- Analytical Data Analysis for the Bioprocessing Industry – 23-26 April 2018
- Vaccine Bioprocess Development and Commercialisation – 16-18 May 2018
- Bioprocess Design & Economic Evaluation – 4 – 7 June 2018
- Bioprocess Facility Design – 25-28 June 2018
- Cell and Gene Therapy Bioprocessing – 9-11 July 2018
A new online MBI module on Industrial Biotechnology: Biocatalysis through to Synthetic Biology will be launched soon.
Yu can find out more about the MBI courses here.
If you would like to discuss opportunities and support mechanisms for biotechnology innovations please contact a member of KTN’s Biotechnology Team.
If you enjoyed this news story, you might also like to read:
You may also be interested in this KTN event: